Literature DB >> 31437741

Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study.

Stephan Schmidt1, Petra Jöstingmeyer2.   

Abstract

BACKGROUND: Quality of life (QoL) is significantly impaired in patients with Multiple Sclerosis (MS). As the expanded disability status scale (EDSS) inadequately reflects the impact of clinical symptoms on QoL, the present study aimed to identify factors associated with reduced QoL in MS patients.
DESIGN: Single-center cross-sectional study in 260 MS patients.
METHODS: QoL was assessed by the Multiple Sclerosis International QoL Questionnaire (MusiQoL), depression by the Center for Epidemiological Studies Depression Scale (CES-D scale), and fatigue by the Fatigue Scale for motor function and cognition (FSMC).
RESULTS: 79.6% patients were female and 21.4% male. The mean age was 44.5 ± 11.2 years and the median EDSS 3.0 (range 0.0-8.5). 35.8% had depression and 56.9% moderate to severe fatigue. The mean MusiQoL index score was 73.9 ± 11.3. Using linear regression, depression, fatigue, family status, physical activity, and occupation were associated with QoL. EDSS was only associated with QoL in patients with an EDSS 0.5.0.
CONCLUSIONS: Depression, fatigue, family status, physical activity, and occupational status were closely associated with QoL in MS patients. Potential measures to improve QoL include assessment and treatment of depression, physical exercise, and maintaining patients employed in accordance with their physical and mental disabilities.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Depression; Edss; Fatigue; Multiple sclerosis; Quality of life

Mesh:

Year:  2019        PMID: 31437741     DOI: 10.1016/j.msard.2019.07.029

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  7 in total

1.  Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Authors:  Susan K Conroy; Katherine B Brownlowe; Thomas W McAllister
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

2.  Quality of life in adults with multiple sclerosis: a systematic review.

Authors:  Irene Gil-González; Agustín Martín-Rodríguez; Rupert Conrad; María Ángeles Pérez-San-Gregorio
Journal:  BMJ Open       Date:  2020-11-30       Impact factor: 2.692

Review 3.  Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review.

Authors:  Bryan E Davis; Lynsey Lakin; Cherie C Binns; Keisha M Currie; Mary R Rensel
Journal:  Neurol Ther       Date:  2021-04-20

4.  Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.

Authors:  Abril Oliva Ramirez; Alexander Keenan; Olivia Kalau; Evelyn Worthington; Lucas Cohen; Sumeet Singh
Journal:  BMC Neurol       Date:  2021-12-02       Impact factor: 2.474

5.  Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.

Authors:  Bruno Kusznir Vitturi; Alborz Rahmani; Guglielmo Dini; Alfredo Montecucco; Nicoletta Debarbieri; Paolo Bandiera; Mario Alberto Battaglia; Tommaso Manacorda; Benedetta Persechino; Giuliana Buresti; Michela Ponzio; Matilde Inglese; Paolo Durando
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

6.  Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab.

Authors:  Matthew Craner; Yaser Al Malik; Fawzi A Babtain; Foziah Alshamrani; Mona M Alkhawajah; Nora Alfugham; Rumaiza H Al-Yafeai; Salman Aljarallah; Seraj Makkawi; Shireen Qureshi; Marina Ziehn; Hazem Wahba
Journal:  Neurol Ther       Date:  2022-09-01

Review 7.  IL-6 and TNF-α responses to acute and regular exercise in adult individuals with multiple sclerosis (MS): a systematic review and meta-analysis.

Authors:  Parnian Shobeiri; Homa Seyedmirzaei; Nastaran Karimi; Fatemeh Rashidi; Antônio L Teixeira; Serge Brand; Dena Sadeghi-Bahmani; Nima Rezaei
Journal:  Eur J Med Res       Date:  2022-09-26       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.